openPR Logo
Press release

Lung Cancer and Therapies Meet 2019

11-12-2018 07:32 PM CET | Health & Medicine

Press release from: Lexis Conferences

Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products.
It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens the latest treatment advancements in Lung Cancer and the researchers around the globe who concentrates on growth about ongoing advances like first stage analysis to treatment etc., this is the best chance to achieve the biggest array of members.
This conference invites Oncologists, Academicians, Physicians, Academic scientists, Radiologists, Chemo therapists, Industry professionals, Head of the departments, Directors, Clinical Professionals, Young researchers, Postgraduates, Trainees and above all Lung cancer Researchers. It also gives the best opportunity to the Business professionals to represent their company.
Lung Cancer Therapies Meet 2019 cordially conducted by the Lexis in Berlin, Germany on May 17-18, 2019 mainly focuses on cause and cure for the Lung Cancer which is the second major cancer causing death to the people around the world. The congress runs with the theme “Interchanging the Scientific Enlightenment about Lung Diseases and Research”.
For more details please follow: https://www.lexisconferences.com/lungcancer
Further queries please feel free to contact us

Thanks & Regards
Sarah Williams
Program Director | Euro Lung Cancer 2019
E: lungcancer@lexisevent.com
4211 Rainier Street, Irving
Texas 75062, USA | T: +1 (214) 972-2216
|||||Lexis

Lexis with the indomitable aim of transforming the fields of Science, Technology and Healthcare, Lexis matches our unshakeable service ethos to the most skilled and enthusiastic professionals. Through our expertise in publishing, event and association management, our goal is to support the scientific communities and networks, as we combine to propel science and health into the future. Lexis believes in integrating innovation with the latest research to remain the preeminent event organizer

4211 Rainier Street, Irving
Texas 75062, USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer and Therapies Meet 2019 here

News-ID: 1359057 • Views:

More Releases from Lexis Conferences

Pharma 2020 Webinar: August 17-18, 2020
Pharma 2020 Webinar: August 17-18, 2020
If we look at the history, innovations don't come just from giving people incentives, it comes from creating an environment where their ideas can connect. Nobody won't get ahead by hiding behind old habits and skills; everyone needs to collaborate with the smartest minds in the field. Scientific congresses are still the best way to do that. Pharma 2020 will have its main focus in discussing the latest high impact
International Conference on Gastroenterology and Digestive Disorders
It is our extraordinary delight to invite you to the International conference organized by LexisConferences scheduled in Vancouver, Canada during July 27-28, 2020. The conference is organized around the theme "Future Perspectives and shaping trends in Gastroenterology and Digestive Disorders". Gastroenterology and Digestive Disorders 2020 will encourage dialogs and wants to rouse members from a wide cluster of research to start joint efforts inside and over the order of Gastroenterology

More Releases for Lung

Lung Cancer Surgery Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Lung Cancer Surgery Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the Lung Cancer Surgery Market. Increased demand for the technologies is also one of the factors, which are likely to boost the growth of this industry. The
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor
11-11-2019 | Health & Medicine
CMI
Higher carcinoma lung population dominates the lung cancer therapeutics market
Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small cell and small cell lung cancer and originates from the epithelial cells. Lung cancer has the highest mortality rate globally, where exposure to asbestos, cigarette and pipe
Lung Management Products Market Soaring Demand Assures Motivated Revenue Share d …
Lung management products are required for patients dealing with severe conditions such as asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and lung cancers. Lung management products are also used as a home-based care to exercise lungs and keep them healthy for a longer run. Several lung exercisers are available and being highly preferred. According to the American Lung Association, lung cancer was the most common cancer type in 2015
Artificial Lung Market Key Players 2018 - Haemair Ltd, Lung Biotechnology PBC, a …
Artificial Lung Overview: Medical Devices sector report, “Artificial Lung - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start
Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents What are Cancer Vaccines? Mechanism of Cancer Vaccines 2.1 Idiotype Cancer Vaccine Mechanism 2.2 Cellular Cancer Vaccines Mechanism 2.3 Ganglioside Antigens based Cancer Vaccines Mechanism 2.4 Peptide Cancer Vaccine Mechanism 2.5 Tumor Host Interaction Cancer Vaccine Mechanism Overview of Lung Cancer Proliferation 3.1 Lung Cancer Invasion 3.1.1 Transformation of Normal Cell into